Yoshiyasu Umeda

Immune evasion through mitochondrial transfer in the tumour microenvironment

Hideki Ikeda, Katsushige Kawase, Tatsuya Nishi et al. · Nature · 2025 · 166 citations · Full text

TIGIT/CD155 axis mediates resistance to immunotherapy in patients with melanoma with the inflamed tumor microenvironment

Shusuke Kawashima, Takashi Inozume, Masahito Kawazu et al. · Journal for ImmunoTherapy of Cancer · 2021 · 83 citations · Full text

Anti-PD-1 antibody monotherapy versus anti-PD-1 plus anti-CTLA-4 combination therapy as first-line immunotherapy in unresectable or metastatic mucosal melanoma: a retrospective, multicenter study of 329 Japanese cases (JMAC study)

Yasuhiro Nakamura, Kenjiro Namikawa, Shusuke Yoshikawa et al. · ESMO Open · 2021 · 50 citations · Full text

Real-world efficacy of anti-PD-1 antibody or combined anti-PD-1 plus anti-CTLA-4 antibodies, with or without radiotherapy, in advanced mucosal melanoma patients: A retrospective, multicenter study

Yoshiyasu Umeda, Shusuke Yoshikawa, Yukiko Kiniwa et al. · European Journal of Cancer · 2021 · 39 citations

Cancer Immunosurveillance, Anti-ctla-4 Antibodies, Medicine +10

Efficacy comparison between anti-PD-1 antibody monotherapy and anti-PD-1 plus anti-CTLA-4 combination therapy as first-line immunotherapy for advanced acral melanoma: A retrospective, multicenter study of 254 Japanese patients

Yasuhiro Nakamura, Kenjiro Namikawa, Yukiko Kiniwa et al. · European Journal of Cancer · 2022 · 39 citations

Advanced Acral Melanoma, Efficacy Comparison, Medicine +9